Cystic-fibrosis-focused Sionna Therapeutics made its public debut this week, with an upsized public offering. Meanwhile, Titan America had a ...

Sionna Therapeutics (NASDAQ:SION), a clinical-stage biopharma focused on developing cystic fibrosis therapies, opened well above its initial public offering price on Friday in its first trading ...

Young federal workers gathered at DC9, a Washington bar offering cheap drinks for any government employee as the deadline to ...

There is near consensus by capital markets experts that the initial public offering market is open, and will remain open ...

Porsche AG is falling further off track from lofty targets set during its splashy stock listing two years ago, with costs mounting from executives having misjudged how eager sports-car buyers were to ...

Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital ...

As private capital markets surged in recent years, the ability for private credit and private equity assets to seep into ...

Northpointe Bancshares is targeting a valuation of up to $595 million in its initial public offering in the United States, ...

IPO-bound Droom's financial health has declined, with its revenue from operations nosediving by two-thirds during the last ...

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing ...

Some Iowans have raised concerns following allegations that Lutheran churches and organizations are using federal grants as a ...

Titan America SA and its owner Titan Cement International SA raised $384 million in an initial public offering, pricing its ...